Argus
•
Sep 02, 2026
BLFS: Lowering target price to $37.00
Summary
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry.
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
COLL: Lowering target price to $23.00
Sep 02, 2026
•
COLL
VCEL: Lowering target price to $43.00
Sep 02, 2026
•
VCEL
VCYT: What does Argus have to say about VCYT?
Sep 02, 2026
•
VCYT
XNCR: Lowering target price to $29.00
Sep 02, 2026
•
XNCR
Daily – Vickers Top Buyers & Sellers for 08/28/2026
Aug 28, 2026
•
GEN, IPGP, FIX, SGI, CRS, KDP, CNC, RGNX, CURB, CODI
